Argent BioPharma Limited (RGTLF)
OTCMKTS · Delayed Price · Currency is USD
0.0900
0.00 (0.00%)
At close: Apr 23, 2025

Argent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Market Capitalization
5911306422
Upgrade
Market Cap Growth
-51.68%-18.72%-62.93%-53.08%194.62%-50.82%
Upgrade
Enterprise Value
101117276522
Upgrade
Last Close Price
0.090.214.0013.6030.1030.00
Upgrade
PS Ratio
26.8815.244.959.2328.5415.16
Upgrade
PB Ratio
-0.73-2.33-2.098.436.1810.18
Upgrade
P/TBV Ratio
---16.2212.6010.15
Upgrade
EV/Sales Ratio
55.2318.037.388.3828.7215.56
Upgrade
Debt / Equity Ratio
-0.86-1.67-1.210.840.440.61
Upgrade
Asset Turnover
0.030.090.240.220.190.20
Upgrade
Inventory Turnover
0.861.071.273.082.987.04
Upgrade
Quick Ratio
0.080.100.060.501.270.79
Upgrade
Current Ratio
0.160.230.190.841.551.09
Upgrade
Return on Equity (ROE)
----218.54%-187.61%-270.21%
Upgrade
Return on Assets (ROA)
-121.60%-108.58%-66.60%-45.27%-46.40%-67.42%
Upgrade
Return on Capital (ROIC)
-282.13%-401.12%-168.89%-65.95%-60.09%-89.33%
Upgrade
Earnings Yield
-284.37%-129.05%-124.29%-46.61%-18.56%-61.45%
Upgrade
FCF Yield
-140.29%-108.97%-72.67%-34.02%-17.91%-34.65%
Upgrade
Buyback Yield / Dilution
-284.88%-1155.86%-14.85%-34.63%-37.91%-14.31%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.